Literature DB >> 17537837

Placental insufficiency results in temporal alterations in the renin angiotensin system in male hypertensive growth restricted offspring.

Daniela Grigore1, Norma B Ojeda, Elliot B Robertson, Antoinette S Dawson, Contrina A Huffman, Erick A Bourassa, Robert C Speth, K Bridget Brosnihan, Barbara T Alexander.   

Abstract

Reduced uterine perfusion initiated in late gestation in the rat results in intrauterine growth restriction (IUGR) and development of hypertension by 4 wk of age. We hypothesize that the renin angiotensin system (RAS), a regulatory system important in the long-term control of blood pressure, may be programmed by placental insufficiency and may contribute to the etiology of IUGR hypertension. We previously reported that RAS blockade abolished hypertension in adult IUGR offspring; however, the mechanisms responsible for the early phase of hypertension are unresolved. Therefore, the purpose of this study was to examine RAS involvement in early programmed hypertension and to determine whether temporal changes in RAS expression are observed in IUGR offspring. Renal renin and angiotensinogen mRNA expression were significantly decreased at birth (80 and 60%, respectively); plasma and renal RAS did not differ in conjunction with hypertension (mean increase of 14 mmHg) in young IUGR offspring; however, hypertension (mean increase of 22 mmHg) in adult IUGR offspring was associated with marked increases in renal angiotensin-converting enzyme (ACE) activity (122%) and renal renin and angiotensinogen mRNA (7-fold and 7.4-fold, respectively), but no change in renal ANG II or angiotensin type 1 receptor. ACE inhibition (enalapril, 10 mg x kg(-1) x day(-1), administered from 2 to 4 wk of age) abolished hypertension in IUGR at 4 wk of age (decrease of 15 mmHg, respectively) with no significant depressor effect in control offspring. Therefore, temporal alterations in renal RAS are observed in IUGR offspring and may play a key role in the etiology of IUGR hypertension.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17537837      PMCID: PMC2841000          DOI: 10.1152/ajpregu.00725.2006

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  58 in total

Review 1.  Renal renin-angiotensin system.

Authors:  Atsuhiro Ichihara; Hiroyuki Kobori; Akira Nishiyama; L Gabriel Navar
Journal:  Contrib Nephrol       Date:  2004       Impact factor: 1.580

2.  Cardiovascular and renal disease in the adolescent guinea pig after chronic placental insufficiency.

Authors:  Todd A Briscoe; Alexandra E Rehn; Sandra Dieni; Jhodie R Duncan; Mary E Wlodek; Julie A Owens; Sandra M Rees
Journal:  Am J Obstet Gynecol       Date:  2004-09       Impact factor: 8.661

3.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

4.  Kidney angiotensin and angiotensin receptor expression in prenatally programmed hypertension.

Authors:  V Matti Vehaskari; Tyrus Stewart; Derek Lafont; Christopher Soyez; Dale Seth; Jennifer Manning
Journal:  Am J Physiol Renal Physiol       Date:  2004-04-20

5.  Effect of enalapril (MK-421), an orally active angiotensin I converting enzyme inhibitor, on blood pressure, active and inactive plasma renin, urinary prostaglandin E2, and kallikrein excretion in conscious rats.

Authors:  E L Schiffrin; J Gutkowska; G Thibault; J Genest
Journal:  Can J Physiol Pharmacol       Date:  1984-01       Impact factor: 2.273

6.  Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology.

Authors:  D O'Regan; C J Kenyon; J R Seckl; M C Holmes
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-07-06       Impact factor: 4.310

Review 7.  The role of the RAS in programming of adult hypertension.

Authors:  R Rasch; E Skriver; L L Woods
Journal:  Acta Physiol Scand       Date:  2004-08

8.  Renin and angiotensinogen gene expression in maturing rat kidney.

Authors:  R A Gomez; K R Lynch; R L Chevalier; N Wilfong; A Everett; R M Carey; M J Peach
Journal:  Am J Physiol       Date:  1988-04

9.  Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats.

Authors:  Akira Nishiyama; Masanori Yoshizumi; Matlubur Rahman; Hiroyuki Kobori; Dale M Seth; Akira Miyatake; Guo-Xing Zhang; Li Yao; Hirofumi Hitomi; Takatomi Shokoji; Hideyasu Kiyomoto; Shoji Kimura; Toshiaki Tamaki; Masakazu Kohno; Youichi Abe
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

10.  Prenatal programming of angiotensin II type 2 receptor expression in the rat.

Authors:  Sarah McMullen; David S Gardner; Simon C Langley-Evans
Journal:  Br J Nutr       Date:  2004-01       Impact factor: 3.718

View more
  45 in total

Review 1.  Epigenetics and developmental programming of adult onset diseases.

Authors:  Lee O'Sullivan; Alexander N Combes; Karen M Moritz
Journal:  Pediatr Nephrol       Date:  2012-12       Impact factor: 3.714

Review 2.  Intrauterine growth restriction: fetal programming of hypertension and kidney disease.

Authors:  Norma B Ojeda; Daniela Grigore; Barbara T Alexander
Journal:  Adv Chronic Kidney Dis       Date:  2008-04       Impact factor: 3.620

3.  Activation of the sympathetic nervous system, is it key to the developmental origins of enhanced cardiovascular risk?

Authors:  Barbara T Alexander; Suttira Intapad
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-05

Review 4.  How the kidney is impacted by the perinatal maternal environment to develop hypertension.

Authors:  Ana D Paixão; Barbara T Alexander
Journal:  Biol Reprod       Date:  2013-12-19       Impact factor: 4.285

5.  Maternal protein restriction reduces expression of angiotensin I-converting enzyme 2 in rat placental labyrinth zone in late pregnancy.

Authors:  Haijun Gao; Uma Yallampalli; Chandra Yallampalli
Journal:  Biol Reprod       Date:  2012-02-09       Impact factor: 4.285

Review 6.  Sex differences in the fetal programming of hypertension.

Authors:  Daniela Grigore; Norma B Ojeda; Barbara T Alexander
Journal:  Gend Med       Date:  2008

Review 7.  Developmental programming of hypertension: insight from animal models of nutritional manipulation.

Authors:  Norma B Ojeda; Daniela Grigore; Barbara T Alexander
Journal:  Hypertension       Date:  2008-05-12       Impact factor: 10.190

8.  Role of fetal programming in the development of hypertension.

Authors:  Norma B Ojeda; Daniela Grigore; Barbara T Alexander
Journal:  Future Cardiol       Date:  2008-03

9.  Childhood kidney outcomes in relation to fetal blood flow and kidney size.

Authors:  Marjolein N Kooijman; Hanneke Bakker; Albert J van der Heijden; Albert Hofman; Oscar H Franco; Eric A P Steegers; H Rob Taal; Vincent W V Jaddoe
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

10.  Fetal and infant growth patterns and kidney function at school age.

Authors:  Hanneke Bakker; Romy Gaillard; Oscar H Franco; Albert Hofman; Albert J van der Heijden; Eric A P Steegers; H Rob Taal; Vincent W V Jaddoe
Journal:  J Am Soc Nephrol       Date:  2014-05-08       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.